Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis
Rapid and dependable methods for isolating human pluripotent stem cell (hPSC) populations are urgently needed for quality control in basic research and in cell-based therapy applications. Using lectin arrays, we analyzed glyco- proteins extracted from 26 hPSC samples and 22 differentiated cell sampl...
Saved in:
Published in | Cell research Vol. 21; no. 11; pp. 1551 - 1563 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.11.2011
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Rapid and dependable methods for isolating human pluripotent stem cell (hPSC) populations are urgently needed for quality control in basic research and in cell-based therapy applications. Using lectin arrays, we analyzed glyco- proteins extracted from 26 hPSC samples and 22 differentiated cell samples, and identified a small group of lectins with distinctive binding signatures that were sufficient to distinguish hPSCs from a variety of non-pluripotent cell types. These specific biomarkers were shared by all the 12 human embryonic stem cell and the 14 human induced pluripotent stem cell samples examined, regardless of the laboratory of origin, the culture conditions, the somatic cell type reprogrammed, or the reprogramming method used. We demonstrated a practical application of specific lectin binding by detecting hPSCs within a differentiated cell population with lectin-mediated staining followed by fluores- cence microscopy and flow cytometry, and by enriching and purging viable hPSCs from mixed cell populations using lectin-mediated cell separation. Global gene expression analysis showed pluripotency-associated differential expres- sion of specific fucosyltransferases and sialyltransferases, which may underlie these differences in protein glycosy- lation and lectin binding. Taken together, our results show that protein glycosylation differs considerably between pluripotent and non-pluripotent cells, and demonstrate that lectins may be used as biomarkers to monitor pluripo- tency in stem cell populations and for removal of viable hPSCs from mixed cell population |
---|---|
Bibliography: | Rapid and dependable methods for isolating human pluripotent stem cell (hPSC) populations are urgently needed for quality control in basic research and in cell-based therapy applications. Using lectin arrays, we analyzed glyco- proteins extracted from 26 hPSC samples and 22 differentiated cell samples, and identified a small group of lectins with distinctive binding signatures that were sufficient to distinguish hPSCs from a variety of non-pluripotent cell types. These specific biomarkers were shared by all the 12 human embryonic stem cell and the 14 human induced pluripotent stem cell samples examined, regardless of the laboratory of origin, the culture conditions, the somatic cell type reprogrammed, or the reprogramming method used. We demonstrated a practical application of specific lectin binding by detecting hPSCs within a differentiated cell population with lectin-mediated staining followed by fluores- cence microscopy and flow cytometry, and by enriching and purging viable hPSCs from mixed cell populations using lectin-mediated cell separation. Global gene expression analysis showed pluripotency-associated differential expres- sion of specific fucosyltransferases and sialyltransferases, which may underlie these differences in protein glycosy- lation and lectin binding. Taken together, our results show that protein glycosylation differs considerably between pluripotent and non-pluripotent cells, and demonstrate that lectins may be used as biomarkers to monitor pluripo- tency in stem cell populations and for removal of viable hPSCs from mixed cell population Yu-Chieh Wang , Masato Nakagawa3, Ibon Garitaonandia Ileana Slavin1' 2 Gulsah Altun, Robert M Lacharite Kristopher L Nazor1' 2, Ha T Tran1' 2 Candace L Lynch, Trevor R Leonardo, Ying Liu, Suzanne E Peterson Louise C Laurent, 7, Shinya Yamanaka , 6, Jeanne F Loring, The Scripps Research Institute, Department of Chemical Physiology, La Jolla, CA 92037, USA; 2The Scripps Research Institute, Center for Regenerative Medicine, 10550 N. Torrey Pines Rd, SP-3021, La Jolla, CA 92037, USA," 3Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan; 4Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan; 5Japan Science and Technology Agency, Yamanaka iPS Cell Special Project, Kawaguchi, Japan; 6Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158-2261, USA; 7Department of Reproductive Medicine, University of California, San Diego, La Jolla, CA, USA 31-1568/Q lectins; glycosylation; pluripotency biomarkers; human pluripotent stem cell; induced pluripotent stem cells; em- bryonic stem cells ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ISSN: | 1001-0602 1748-7838 1748-7838 |
DOI: | 10.1038/cr.2011.148 |